LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 51 filers reported holding LEAP THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,287,009 | -24.4% | 6,726,496 | 0.0% | 0.07% | -20.0% |
Q4 2022 | $3,026,923 | -54.0% | 6,726,496 | -10.0% | 0.08% | -55.5% |
Q3 2022 | $6,575,000 | -28.1% | 7,472,148 | -6.0% | 0.19% | -33.2% |
Q2 2022 | $9,144,000 | -34.3% | 7,951,448 | 0.0% | 0.29% | +2.5% |
Q1 2022 | $13,915,000 | -74.7% | 7,951,448 | -53.1% | 0.28% | -34.2% |
Q4 2021 | $54,926,000 | +61.6% | 16,952,992 | +100.0% | 0.42% | -14.2% |
Q3 2021 | $33,990,000 | +22.3% | 8,476,496 | -50.0% | 0.49% | +172.9% |
Q2 2021 | $27,802,000 | +72.6% | 16,952,992 | +100.0% | 0.18% | -11.3% |
Q1 2021 | $16,105,000 | -15.6% | 8,476,496 | 0.0% | 0.20% | -0.5% |
Q4 2020 | $19,072,000 | +13.6% | 8,476,496 | 0.0% | 0.20% | -16.3% |
Q3 2020 | $16,783,000 | -3.9% | 8,476,496 | 0.0% | 0.24% | -13.4% |
Q2 2020 | $17,466,000 | +64.4% | 8,476,496 | +26.0% | 0.28% | +2.2% |
Q1 2020 | $10,627,000 | – | 6,726,496 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 16,952,992 | $27,802,000 | 0.18% |
Opaleye Management Inc. | 540,000 | $886,000 | 0.15% |
ACT CAPITAL MANAGEMENT, LLC | 134,000 | $220,000 | 0.11% |
Artal Group S.A. | 3,000,000 | $4,920,000 | 0.10% |
HHLR ADVISORS, LTD. | 3,575,745 | $5,864,000 | 0.06% |
PLATINUM INVESTMENT MANAGEMENT LTD | 910,047 | $1,492,000 | 0.04% |
PERSONAL CFO SOLUTIONS, LLC | 78,165 | $128,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 122,401 | $201,000 | 0.02% |
Windsor Creek Advisors, LLC | 46,955 | $77,000 | 0.02% |
Golden Green, Inc. | 14,824 | $24,000 | 0.02% |